Brief: Illumina Enhances Flagship Assay To Accelerate Access To Comprehensive Tumor Profiling
30/07/2025 14:58
July 30 (Reuters) - Illumina Inc ILMN.O: ILLUMINA ENHANCES FLAGSHIP ASSAY TO ACCELERATE ACCESS TO COMPREHENSIVE TUMOR PROFILING Source text: ID:nPn29ngJma Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsRoche launches Axelios gene sequencer in a bid to loosen Illumina's grip (updated)
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner